Gastrointestinal Nematodes in Sheep: Anthelmintic Resistance

Introduction

Gastrointestinal nematode (GIN) infections represent a major constraint to sheep production worldwide. The most pathogenic species include Haemonchus contortus, Teladorsagia circumcincta, and Trichostrongylus spp. [1, 2]. For decades, control has relied on the frequent administration of broad-spectrum anthelmintics belonging to three main classes: benzimidazoles (BZ), macrocyclic lactones (ML), and imidazothiazoles (e.g., levamisole). However, the widespread evolution of anthelmintic resistance (AR) has severely compromised the efficacy of these drugs, with multi-drug resistant populations now reported on every continent [3, 4]. This article provides a detailed review of the biology of key GIN species, the molecular mechanisms underlying AR, diagnostic approaches including the fecal egg count reduction test (FECRT) and molecular assays, and sustainable control strategies.

Major Gastrointestinal Nematode Species in Sheep

The primary GIN species affecting sheep vary by geographic region and climate. Table 1 summarizes the most economically important species.

Table 1. Key Gastrointestinal Nematodes of Sheep.

H. contortus is particularly notorious for its rapid development of resistance to multiple anthelmintic classes [5, 6]. T. circumcincta is the dominant species in temperate regions and shows extensive resistance to BZ and ML drugs [7, 8]. The pathophysiology of these infections is linked to their feeding habits and mucosal damage, which impair nutrient absorption and induce immune dysregulation [9].

Anthelmintic Classes and Mechanisms of Resistance

Three main anthelmintic classes have been used extensively in sheep. Resistance mechanisms are class-specific but share common themes of target-site mutations and increased drug efflux.

Benzimidazoles

Benzimidazoles (e.g., albendazole, fenbendazole) bind to (\beta)-tubulin, disrupting microtubule polymerization in nematode intestinal cells [10]. Resistance is primarily associated with single nucleotide polymorphisms (SNPs) in the (\beta)-tubulin isotype 1 gene (tbb-iso-1), particularly at codons 167, 198, and 200 [11, 12]. The F200Y mutation (TTC to TAC) is the most prevalent in H. contortus and T. circumcincta [13, 14]. These mutations reduce drug binding affinity, allowing microtubule formation to proceed.

Resistance to BZs is inherited as a recessive trait, but field selection rapidly increases allele frequencies under repeated drug pressure [15].

Macrocyclic Lactones

Macrocyclic lactones (ivermectin, moxidectin) potentiate glutamate-gated chloride channels (GluCls) causing paralysis of pharyngeal and somatic muscles [16]. Resistance mechanisms are polygenic. Key contributors include:

• Overexpression of P-glycoprotein (Pgp) efflux transporters, which reduce drug accumulation at target sites [17, 18].
• Mutations in GluCl subunit genes (e.g., avr-14, avr-15) that alter channel sensitivity [19].
• Reduced cuticular penetration of drug in resistant isolates [20].

Resistance to MLs can develop more slowly than to BZs, but once established it is often persistent and cross-resistance among MLs is common [21]. Moxidectin retains partial efficacy against some ivermectin-resistant isolates because of its higher lipophilicity and slower elimination [22].

Imidazothiazoles and Tetrahydropyrimidines

Levamisole and morantel are nicotinic acetylcholine receptor (nAChR) agonists that cause spastic paralysis [23]. Resistance involves loss of functional nAChR subtypes, particularly the L-AChR (levamisole-sensitive) due to deletion or downregulation of the unc-63 and unc-29 subunit genes [24, 25]. Resistance to levamisole is less widespread than BZ or ML resistance but is increasing in regions where levamisole has been used intensively [26].

Multi-Drug Resistance

The coexistence of resistance to two or more classes within a single nematode population is now common [27]. H. contortus isolates with triple-resistance (BZ, ML, levamisole) have been reported from Australia, South Africa, and South America [28, 29]. The genetic mechanisms overlap; for example, Pgp overexpression can contribute to both ML and BZ resistance [30].

Diagnostic Methods for Anthelmintic Resistance

Accurate detection of AR is essential for informed treatment decisions and resistance management.

Fecal Egg Count Reduction Test

The FECRT is the gold standard field test for AR [31, 32]. It compares pre-treatment and post-treatment fecal egg counts (FECs) in a group of animals. The World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines define resistance when the percentage reduction in FEC is less than 95% and the lower 95% confidence interval is below 90% [33].

Table 2. FECRT Interpretation (adapted from WAAVP).

The FECRT is influenced by factors such as egg count variability, calculation method (e.g., arithmetic vs. geometric means), and the need for appropriate control groups [34]. Bayesian approaches improve accuracy when sample sizes are small [35].

Molecular Diagnostic Assays

Molecular methods allow detection of resistance alleles before phenotypic failure becomes apparent.

Allele-specific PCR (AS-PCR) : Detects BZ resistance SNPs (F200Y, E198A, F167Y) in H. contortus and T. circumcincta [36, 37]. Pyrosequencing provides quantitative allele frequency data from pooled larval samples [38].

Quantitative PCR (qPCR) : Measures Pgp gene expression levels in ML-resistant isolates. Upregulation of Hco-pgp-9 and Hco-pgp-11 correlates with ivermectin resistance in H. contortus [39].

Next-generation sequencing (NGS) : Targeted amplicon sequencing of resistance-associated genes enables simultaneous screening of multiple SNPs and copy number variations [40]. NGS-based approaches are increasingly used in research settings to track resistance evolution.

Larval Development Assays and In Vitro Tests

The larval development assay (LDA) measures drug sensitivity by quantifying the proportion of L1 larvae that develop to L3 in the presence of drug concentrations [41]. Other in vitro tests include the egg hatch test (EHT) for BZ resistance and the larval migration inhibition test (LMIT) for ML and levamisole resistance [42, 43].

Figure 1 presents a decision algorithm for AR diagnosis in a sheep flock.

flowchart TD
    A[Clinical suspicion or production loss], > B[Collect fecal samples <br/>(≥10 animals per group)]
    B, > C[Perform pre-treatment FEC]
    C, > D{Mean FEC > 200 epg?}
    D, >|No| E[Reconsider sampling or treat based on risk]
    D, >|Yes| F[Administer anthelmintic at correct dose]
    F, > G[Collect post-treatment samples <br/>(7-14 days for BZ, 14-17 for ML)]
    G, > H[Perform post-treatment FEC]
    H, > I[Calculate FECRT percentage <br/>and 95% CI]
    I, > J{Reduction < 90%?}
    J, >|No| K[Likely susceptible]
    J, >|Yes| L[Resistance suspected]
    L, > M[Confirm with molecular assay <br/>e.g., AS-PCR for BZ SNPs]
    M, > N[Identify class-specific resistance]
    N, > O[Implement integrated management]

Sustainable Control Strategies

Given the rapid spread of AR, sustainable control must integrate multiple approaches that reduce reliance on anthelmintics.

Targeted Selective Treatment

Targeted selective treatment (TST) uses individual animal indicators (e.g., FAMACHA score for anemia, dag score for diarrhea, liveweight gain) to treat only those animals that require intervention [44]. This maintains a reservoir of susceptible nematodes in refugia, slowing resistance development [45]. The FAMACHA system, which scores conjunctival color from 1 to 5, is particularly effective for H. contortus control [46].

Grazing Management and Pasture Hygiene

Strategic pasture rotation, co-grazing with cattle or other species, and resting pastures reduce larval contamination [47]. For example, alternating sheep and cattle grazing breaks the nematode life cycle because most ovine GIN species are host-specific [48]. For further details on fluke control, see Fasciolosis in Cattle and Sheep: Liver Fluke Diagnosis via Coproantigen ELISA, Pooled PCR, and Anthelmintic Resistance to Triclabendazole. Additionally, understanding Coccidiosis in Calves: Eimeria Species, Pathophysiology, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts can inform broader parasite control programs in young ruminants.

Vaccine Development

A vaccine against H. contortus based on native gut antigens (H11 and H-gal-GP) has shown variable efficacy under field conditions [49]. Recombinant subunit vaccines are under development, but commercial availability remains limited [50].

Genetic Selection of Host Resistance

Breeding sheep with increased genetic resistance to GINs offers a long-term sustainable solution. Selection based on fecal egg counts and immune response traits (e.g., IgA levels) has produced measurable improvements in resistance in some lines [51, 52].

Conclusion

Anthelmintic resistance in ovine gastrointestinal nematodes, particularly H. contortus and T. circumcincta, is a global crisis that threatens the productivity and welfare of sheep flocks. Resistance to BZ and ML classes is widespread, driven by well-characterized genetic mechanisms. The FECRT remains the cornerstone of field diagnosis, supplemented by molecular assays that reveal the genetic basis of resistance. Sustainable control must move beyond repeated chemotherapy toward integrated approaches including TST, grazing management, vaccination, and genetic selection. Continued research into novel drug targets and the population genetics of resistance will be essential to prolong the efficacy of existing anthelmintics and develop new tools.

References

[1] Roeber F, Jex AR, Gasser RB. Impact of gastrointestinal parasitic nematodes of sheep, and the role of advanced molecular tools for exploring epidemiology and drug resistance. Vet Parasitol. 2013;193(1-3):23-42.

[2] Besier RB, Kahn LP, Sargison ND, Van Wyk JA. The pathophysiology, ecology and epidemiology of Haemonchus contortus infection in small ruminants. Adv Parasitol. 2016;93:95-143.

[3] Kaplan RM, Vidyashankar AN. An inconvenient truth: diagnosis of anthelmintic resistance in ruminants. Vet Parasitol. 2012;186(1-2):70-78.

[4] Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends Parasitol. 2004;20(10):469-476.

[5] Gill JH, Lacey E. Benzimidazole resistance in Haemonchus contortus. Int J Parasitol. 1993;23(3):375-381.

[6] Le Jambre LF. Egg hatch as an in vitro assay of thiabendazole resistance in nematodes. Vet Parasitol. 1976;2(4):385-391.

[7] Sargison ND, Wilson DJ, Bartley DJ, et al. Observations on the emergence of anthelmintic resistance in Teladorsagia circumcincta in sheep flocks in Scotland. Vet Rec. 2005;157(20):619-623.

[8] Gilleard JS, Beech RN. Population genetics of anthelmintic resistance in parasitic nematodes. Parasitology. 2007;134(8):1133-1147.

[9] Gasbarre LC, Leighton EA, Sonstegard T. Role of the bovine immune system and genome in resistance to gastrointestinal nematodes. Vet Parasitol. 2001;98(1-3):51-64.

[10] Lacey E. The role of the cytoskeleton in the biological action of benzimidazoles. Biochem Soc Trans. 1990;18(5):744-745.

[11] Kwa MSG, Kooyman FNJ, Roos MH. (\beta)-tubulin: a good indicator for benzimidazole resistance? Parasitol Today. 1994;10(7):261-265.

[12] von Samson-Himmelstjerna G, Blackhall WJ, McCarthy JS, Skuce PJ. Single nucleotide polymorphism (SNP) markers for benzimidazole resistance in veterinary nematodes. Parasitology. 2007;134(8):1113-1121.

[13] Silvestre A, Humbert JF. Diversity of benzimidazole resistance alleles in the nematode Teladorsagia circumcincta from French sheep flocks. Int J Parasitol. 2002;32(7):857-864.

[14] Ghisi M, Kaminsky R, Mäser P. Phenotyping and genotyping of Haemonchus contortus isolates for resistance to benzimidazoles. Vet Parasitol. 2007;144(3-4):302-310.

[15] Le Jambre LF, Martin PJ, Johnston R. Benzimidazole resistance in nematodes of sheep: inheritance and field testing. Res Vet Sci. 1980;29(3):376-380.

[16] Wolstenholme AJ, Rogers AT. Glutamate-gated chloride channels and the mode of action of ivermectin. Parasitology. 2005;131(S1):S85-S95.

[17] Xu M, Molento M, Blackhall W, Ribeiro P, Beech R, Prichard R. Ivermectin resistance in Haemonchus contortus involves altered P-glycoprotein expression. Mol Biochem Parasitol. 1998;91(2):327-335.

[18] Lespine A, Ménez C, Bourguinat C, Prichard RK. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing resistance. Expert Opin Drug Metab Toxicol. 2008;4(11):1467-1481.

[19] Njue AI, Hayward R, Prichard RK. Ivermectin resistance in Haemonchus contortus: the role of the glutamate-gated chloride channel subunit Hco-GLC-5. Vet Parasitol. 2004;123(1-2):123-131.

[20] Molento MB, Prichard RK. Effects of the multixenobiotic resistance transporter on the pharmacokinetics of ivermectin in Haemonchus contortus. Vet Parasitol. 1999;82(3):229-240.

[21] Leathwick DM, Miller CM, Brown AE, Sutherland IA. The effectiveness of benzimidazole and macrocyclic lactone treatments for sheep nematodes. N Z Vet J. 2001;49(6):213-218.

[22] Craig TM, Hatfield TA, Pankavich JA, Wang GT. Efficacy of moxidectin against ivermectin-resistant Haemonchus contortus in sheep. Vet Parasitol. 1992;41(3-4):311-316.

[23] Martin RJ, Clark CL. The mode of action of levamisole as an anthelmintic. Pharmacol Ther. 1996;68(2):247-263.

[24] Boulin T, Gielen L, Richmond JE, et al. Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor. Proc Natl Acad Sci USA. 2008;105(47):18590-18595.

[25] Neveu C, Charvet CL, Fauvin A, et al. Genetic analysis of levamisole resistance in the parasitic nematode Teladorsagia circumcincta. Mol Biochem Parasitol. 2010;174(2):119-125.

[26] Bartley DJ, Donnan AA, Jackson E, et al. A survey of anthelmintic resistance in sheep flocks in Scotland. Vet Rec. 2003;153(19):579-583.

[27] Wrigley J, McArthur M, McKenna PB, et al. Prevalence of anthelmintic resistance on sheep farms in New Zealand. N Z Vet J. 2006;54(6):304-309.

[28] Love SCJ, Neilson FJA, Biddle AJ, McKenna PB. Anthelmintic resistance in sheep nematodes in Australia: the state of play. Aust Vet J. 2003;81(12):736-740.

[29] Van Wyk JA, Stenson MO, Van der Merwe JS, et al. Anthelmintic resistance in South Africa: survey of sheep farms. J S Afr Vet Assoc. 1999;70(3):136-142.

[30] Blackhall WJ, Prichard RK, Beech RN. P-glycoprotein selection in ivermectin-resistant Haemonchus contortus. Int J Parasitol. 2008;38(7):827-837.

[31] Coles GC, Bauer C, Borgsteede FHM, et al. World Association for the Advancement of Veterinary Parasitology (WAAVP) methods for the detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol. 1992;44(1-2):35-44.

[32] McKenna PB. The detection of anthelmintic resistance in ovine nematodes: a review. N Z Vet J. 1998;46(2):55-60.

[33] Coles GC, Jackson F, Pomroy WE, et al. The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol. 2006;136(3-4):167-185.

[34] Vidyashankar AN, Kaplan RM, Hanlon BM. Statistical methods for analyzing fecal egg count reduction tests. Vet Parasitol. 2012;186(1-2):79-84.

[35] Levecke B, Dobson RJ, Speybroeck N, et al. Novel methods for the diagnosis of drug resistance in parasitic nematodes: a Bayesian approach. Int J Parasitol. 2012;42(2):183-191.

[36] Walsh TK, Donnan AA, Jackson F, et al. Detection and measurement of benzimidazole resistance alleles in Teladorsagia circumcincta using real-time PCR. Int J Parasitol. 2007;37(5):545-554.

[37] Skuce PJ, Stenhouse L, Jackson F, Hyland C, Nisbet AJ. Molecular approaches to the detection of benzimidazole resistance in Haemonchus contortus. Vet Parasitol. 2010;170(3-4):288-295.

[38] von Samson-Himmelstjerna G, Blackhall WJ, McCarthy JS, Skuce PJ. Pyrosequencing for the detection of benzimidazole resistance alleles. Parasitology. 2007;134(8):1121-1128.

[39] Williamson SM, Storey B, Howell S, et al. Candidate genes for ivermectin resistance in Haemonchus contortus. Int J Parasitol. 2011;41(7):773-781.

[40] Gilleard JS. Haemonchus contortus as a paradigm and model to study anthelmintic drug resistance. Parasitology. 2013;140(12):1506-1522.

[41] Hubert J, Kerboeuf D. A microlarval development assay for the detection of anthelmintic resistance in sheep nematodes. Vet Rec. 1992;130(7):139-142.

[42] Le Jambre LF. Egg hatch as an in vitro assay of thiabendazole resistance in nematodes. Vet Parasitol. 1976;2(4):385-391.

[43] Demeler J, Küttler U, von Samson-Himmelstjerna G. Adaptation and evaluation of the larval migration inhibition test for the detection of resistance to macrocyclic lactones in Haemonchus contortus. Vet Parasitol. 2010;172(1-2):106-112.

[44] Van Wyk JA, Bath GF. The FAMACHA system for managing haemonchosis in sheep and goats by clinically identifying individual animals for treatment. Vet Res. 2002;33(5):509-529.

[45] Waghorn TS, Leathwick DM, Pomroy WE, et al. Targeted selective treatment for Haemonchus contortus in lambs: effect on parasite populations and production. Vet Parasitol. 2008;157(3-4):227-235.

[46] Bath GF, Van Wyk JA. The FAMACHA chart for the detection of anaemia in sheep. J S Afr Vet Assoc. 2001;72(1):5-6.

[47] Barger IA. The role of epidemiological knowledge and grazing management for helminth control in sheep. Int J Parasitol. 1999;29(1):41-47.

[48] Niezen JH, Charleston WAG, Hodgson J, et al. Controlling internal parasites in grazing ruminants: grazing management and biological control. Anim Feed Sci Technol. 1996;69(1-3):155-155.

[49] Smith WD, Newlands GFJ, Skuce PJ, et al. Vaccination against Haemonchus contortus with H11 and H-gal-GP. Vet Parasitol. 2001;94(1-2):53-65.

[50] Nisbet AJ, Meeusen ENT, Gonzalez JF, Piedrafita DM. DNA-based vaccines against Haemonchus contortus. Vet Parasitol. 2012;189(1):69-75.

[51] Bishop SC, Stear MJ. The genetics of resistance to nematode parasites in livestock. Livest Prod Sci. 2003;82(2-3):125-140.

[52] Davies G, Stear MJ, Benothman M, et al. Quantitative trait loci associated with parasitic infection in sheep. Anim Genet. 2006;37(4):336-342.